Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20351325

J. Clin. Oncol. 2010 May 1 28 13 2220-6

Download in:

View as

General Info

PMID
20351325